SEC Filings

SEC Filings

Document Date	Description	Filing Group	View
Feb 23, 2023	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-001863.pdf 0001558370-23-001863.rtf 0001558370-23-001863.xls View HTML
Dec 31, 2022	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-001700.pdf 0001558370-23-001700.rtf 0001558370-23-001700.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Feb 22, 2023	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-001703.pdf 0001558370-23-001703.rtf 0001558370-23-001703.xls View HTML
Dec 31, 2022	Registration of securities of foreign private issuers pursuant to section 12(b) or (g)	Annual Filings	0001558370-23-001716.pdf 0001558370-23-001716.rtf 0001558370-23-001716.xls View HTML
Feb 22, 2023	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-001740.pdf 0001558370-23-001740.rtf 0001558370-23-001740.xls View HTML
Feb 06, 2023	A statement of beneficial ownership of common stock by certain persons	Other	0000846087-23-000038.pdf 0000846087-23-000038.rtf 0000846087-23-000038.xls View HTML
Feb 01, 2023	An amendment to the SC 13G filing	Other	0001306550-23-005839.pdf 0001306550-23-005839.rtf View HTML
Jan 30, 2023	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-000681.pdf 0001558370-23-000681.rtf 0001558370-23-000681.xls View HTML
Jan 24, 2023	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-000440.pdf 0001558370-23-000440.rtf 0001558370-23-000440.xls View HTML
Jan 24, 2023	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-000462.pdf 0001558370-23-000462.rtf 0001558370-23-000462.xls View HTML

Data provided by Kaleidoscope.

Who we are

Read about Genmab's purpose, core values and key accomplishments

Learn more
Turning insights into medicine

See the results of innovation that is rooted in science

Explore the pipeline
Innovation for the future

We are developing next-generation technologies

See our technologies

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.

You are now leaving Genmab.com and will be directed to a page intended for U.S. audiences only. Click Continue to confirm you are located in the U.S.